{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:17:44Z","timestamp":1792801064146,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"the Swedish Research Council","doi-asserted-by":"crossref","award":["K2013-52X-20307-07-3"],"award-info":[{"award-number":["K2013-52X-20307-07-3"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"name":"King Gustaf Vs 80-Year Fund","id":[{"id":"https:\/\/ror.org\/02szc9j24","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the V\u00e4sterbotten county council","id":[{"id":"https:\/\/ror.org\/04xvhsp09","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EU-funded FP7 project TRIGGER","award":["FP7-Health-2013-306029"],"award-info":[{"award-number":["FP7-Health-2013-306029"]}]},{"name":"ITN project Rapid","award":["290246"],"award-info":[{"award-number":["290246"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1100-4","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T10:01:03Z","timestamp":1473242463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis"],"prefix":"10.1186","volume":"18","author":[{"given":"Linda","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Sherina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastya","family":"Kharlamova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Potempa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbro","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Israelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Potempa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solbritt","family":"Rantap\u00e4\u00e4-Dahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,7]]},"reference":[{"key":"1100_CR1","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/ard.2010.133371","volume":"70","author":"M Neovius","year":"2011","unstructured":"Neovius M, Simard JF, Askling J, ARTIS study group. Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden. Ann Rheum Dis. 2011;70:624\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1100_CR2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJM199005033221805","volume":"322","author":"ED Harris Jr","year":"1990","unstructured":"Harris Jr ED. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990;322:1277\u201389.","journal-title":"N Engl J Med"},{"key":"1100_CR3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356\u201361.","journal-title":"Nature."},{"key":"1100_CR4","first-page":"383","volume":"60","author":"WJ Venrooij van","year":"2002","unstructured":"van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein\/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med. 2002;60:383\u20138.","journal-title":"Neth J Med."},{"key":"1100_CR5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009;373:659\u201372.","journal-title":"Lancet."},{"key":"1100_CR6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205\u201319.","journal-title":"N Engl J Med."},{"key":"1100_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199002083220606","volume":"322","author":"RC Williams","year":"1990","unstructured":"Williams RC. Periodontal disease. N Engl J Med. 1990;322:373\u201382.","journal-title":"N Engl J Med."},{"key":"1100_CR8","first-page":"70","volume":"35","author":"P Pablo de","year":"2008","unstructured":"de Pablo P, Dietrich T, McAlindon TE. Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population. J Rheumatol. 2008;35:70\u20136.","journal-title":"J Rheumatol."},{"key":"1100_CR9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1600-051X.2011.01776.x","volume":"38","author":"RT Demmer","year":"2011","unstructured":"Demmer RT, Molitor JA, Jacobs Jr DR, Michalowicz BS. Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol. 2011;38:998\u20131006.","journal-title":"J Clin Periodontol."},{"key":"1100_CR10","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.38348","volume":"66","author":"TR Mikuls","year":"2014","unstructured":"Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66:1090\u2013100.","journal-title":"Arthritis Rheumatol."},{"key":"1100_CR11","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/art.34539","volume":"64","author":"JU Scher","year":"2012","unstructured":"Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012;64:3083\u201394.","journal-title":"Arthritis Rheum."},{"key":"1100_CR12","volume":"10","author":"EA Bostrom","year":"2015","unstructured":"Bostrom EA, Kindstedt E, Sulniute R, et al. Increased eotaxin and MCP-1 levels in serum from individuals with periodontitis and in human gingival fibroblasts exposed to pro-inflammatory cytokines. PLoS One. 2015;10, e0134608.","journal-title":"PLoS One."},{"key":"1100_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2249.1997.270-ce1162.x","volume":"107","author":"JL Ebersole","year":"1997","unstructured":"Ebersole JL, Machen RL, Steffen MJ, Willmann DE. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol. 1997;107:347\u201352.","journal-title":"Clin Exp Immunol."},{"key":"1100_CR14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1902\/jop.1987.58.9.607","volume":"58","author":"J Katz","year":"1987","unstructured":"Katz J, Goultschin J, Benoliel R, Brautbar C. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progressing periodontitis. J Periodontol. 1987;58:607\u201310.","journal-title":"J Periodontol"},{"key":"1100_CR15","first-page":"1830","volume":"20","author":"M Heli\u00f6vaara","year":"1993","unstructured":"Heli\u00f6vaara M, Aho K, Aromaa A, Knekt P, Reunanen A. Smoking and risk of rheumatoid arthritis. J Rheumatol. 1993;20:1830\u20135.","journal-title":"J Rheumatol."},{"key":"1100_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1902\/annals.1998.3.1.88","volume":"3","author":"MS Tonetti","year":"1998","unstructured":"Tonetti MS. Cigarette smoking and periodontal diseases: etiology and management of disease. Ann Periodontol. 1998;3:88\u2013101.","journal-title":"Ann Periodontol."},{"key":"1100_CR17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jre.12002","volume":"48","author":"GP Harvey","year":"2013","unstructured":"Harvey GP, Fitzsimmons TR, Dhamarpatni AA, et al. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res. 2013;48:252\u201361.","journal-title":"J Periodontal Res."},{"key":"1100_CR18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43:155\u201363.","journal-title":"Arthritis Rheum."},{"key":"1100_CR19","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","volume":"166","author":"C Masson-Bessi\u00e8re","year":"2001","unstructured":"Masson-Bessi\u00e8re C, Sebbag M, Girbal-Neuhauser E, et al. The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol. 2001;166:4177\u201384.","journal-title":"J Immunol."},{"key":"1100_CR20","volume":"11","author":"K Eriksson","year":"2016","unstructured":"Eriksson K, Nise L, Kats A, et al. Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: a Swedish population based case\u2013control study. PLoS One. 2016;11, e0155956.","journal-title":"PLoS One."},{"key":"1100_CR21","doi-asserted-by":"crossref","unstructured":"Kharlamova N, Jiang X, Sherina N, et al. Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking and risk genes in rheumatoid arthritis etiology. Arthritis Rheumatol. 2016;68:604\u201313.","DOI":"10.1002\/art.39491"},{"key":"1100_CR22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1600-051X.1998.tb02419.x","volume":"25","author":"SS Socransky","year":"1998","unstructured":"Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent Jr RL. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25:134\u201344.","journal-title":"J Clin Periodontol."},{"key":"1100_CR23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nri3785","volume":"15","author":"G Hajishengallis","year":"2015","unstructured":"Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015;15:30\u201344.","journal-title":"Nat Rev Immunol."},{"key":"1100_CR24","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/IAI.67.7.3248-3256.1999","volume":"67","author":"WT McGraw","year":"1999","unstructured":"McGraw WT, Potempa J, Farley D, Travis J. Purification, characterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999;67:3248\u201356.","journal-title":"Infect Immun."},{"key":"1100_CR25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/annrheumdis-2012-202726","volume":"73","author":"AM Quirke","year":"2014","unstructured":"Quirke AM, Lugli EB, Wegner N, et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann Rheum Dis. 2014;73:263\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1100_CR26","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","volume":"62","author":"N Wegner","year":"2010","unstructured":"Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010;62:2662\u201372.","journal-title":"Arthritis Rheum."},{"key":"1100_CR27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10753-004-6641-z","volume":"28","author":"ED Rosenstein","year":"2004","unstructured":"Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria provides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004;28:311\u20138.","journal-title":"Inflammation."},{"key":"1100_CR28","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1002\/art.23936","volume":"58","author":"K Lundberg","year":"2008","unstructured":"Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58:3009\u201319.","journal-title":"Arthritis Rheum."},{"key":"1100_CR29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrrheum.2010.139","volume":"6","author":"K Lundberg","year":"2010","unstructured":"Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA\u2014the citrullinated enolase connection. Nat Rev Rheumatol. 2010;6:727\u201330.","journal-title":"Nat Rev Rheumatol."},{"key":"1100_CR30","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741\u20139.","journal-title":"Arthritis Rheum."},{"key":"1100_CR31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380\u20136.","journal-title":"Arthritis Rheum."},{"key":"1100_CR32","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","volume":"65","author":"VC Willis","year":"2013","unstructured":"Willis VC, Demoruelle MK, Derber LA, et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum. 2013;65:2545\u201354.","journal-title":"Arthritis Rheum."},{"key":"1100_CR33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum."},{"key":"1100_CR34","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","volume":"6","author":"E Berglin","year":"2004","unstructured":"Berglin E, Padyukov L, Sundin U, et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004;6:R303\u20138.","journal-title":"Arthritis Res Ther."},{"key":"1100_CR35","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar1868","volume":"8","author":"M Johansson","year":"2006","unstructured":"Johansson M, Arlestig L, Hallmans G, Rantap\u00e4\u00e4-Dahlqvist S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100\u00a0% for the disease. Arthritis Res Ther. 2006;8:R19.","journal-title":"Arthritis Res Ther."},{"key":"1100_CR36","first-page":"Unit 21.20","volume":"Chapter 21","author":"J Potempa","year":"2007","unstructured":"Potempa J, Nguyen KA. Purification and characterization of gingipains. Curr Protoc Protein Sci. 2007;Chapter 21:Unit 21.20.","journal-title":"Curr Protoc Protein Sci"},{"key":"1100_CR37","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.37835","volume":"65","author":"M Brink","year":"2013","unstructured":"Brink M, Hansson M, Mathsson L, et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 2013;65:899\u2013910.","journal-title":"Arthritis Rheum."},{"key":"1100_CR38","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/aje\/kwn104","volume":"168","author":"GY Zou","year":"2008","unstructured":"Zou GY. On the estimation of additive interaction by use of the four-by-two table and beyond. Am J Epidemiol. 2008;168:212\u201324.","journal-title":"Am J Epidemiol."},{"key":"1100_CR39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1600-051X.2010.01592.x","volume":"37","author":"C Vlachojannis","year":"2010","unstructured":"Vlachojannis C, Dye BA, Herrera-Abreu M, et al. Determinants of serum IgG responses to periodontal bacteria in a nationally representative sample of US adults. J Clin Periodontol. 2010;37:685\u201396.","journal-title":"J Clin Periodontol."},{"key":"1100_CR40","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/art.39118","volume":"67","author":"R Seror","year":"2015","unstructured":"Seror R, Le Gall-David S, Bonnaure-Mallet M, et al. Association of anti Porphyromonas gingivalis antibody titers with nonsmoking status in early rheumatoid arthritis: results from the prospective French cohort of patients with early rheumatoid arthritis. Arthritis Rheumatol. 2015;67:1729\u201337.","journal-title":"Arthritis Rheumatol."},{"key":"1100_CR41","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12891-015-0792-y","volume":"16","author":"BA Fisher","year":"2015","unstructured":"Fisher BA, Cartwright AJ, Quirke AM, et al. Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case\u2013control study. BMC Musculoskelet Disord. 2015;16:331.","journal-title":"BMC Musculoskelet Disord."},{"key":"1100_CR42","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-051X.2004.00597.x","volume":"31","author":"AD Haffajee","year":"2004","unstructured":"Haffajee AD, Bogren A, Hasturk H, et al. Subgingival microbiota of chronic periodontitis subjects from different geographic locations. J Clin Periodontol. 2004;31:996\u20131002.","journal-title":"J Clin Periodontol."},{"key":"1100_CR43","first-page":"117","volume":"99","author":"G Sundqvist","year":"1991","unstructured":"Sundqvist G, Figdor D, H\u00e4nstr\u00f6m L, S\u00f6rlin S, Sandstr\u00f6m G. Phagocytosis and virulence of different strains of Porphyromonas gingivalis. Scand J Dent Res. 1991;99:117\u201329.","journal-title":"Scand J Dent Res."},{"key":"1100_CR44","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.34595","volume":"64","author":"TR Mikuls","year":"2012","unstructured":"Mikuls TR, Thiele GM, Deane KD, et al. Porphyromonas gingivalis and disease related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum. 2012;64:3522\u201330.","journal-title":"Arthritis Rheum."},{"key":"1100_CR45","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/annrheumdis-2013-204594","volume":"73","author":"M Smit de","year":"2014","unstructured":"de Smit M, van de Stadt LA, Janssen KMJ, et al. Antibodies against Porphyromonas gingivalis in seropositive arthralgia patients do not predict development of rheumatoid arthritis. Ann Rheum Dis. 2014;73:1277\u20139.","journal-title":"Ann Rheum Dis."}],"updated-by":[{"DOI":"10.1186\/s13075-016-1164-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T00:00:00Z","timestamp":1478217600000}}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1100-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T03:16:50Z","timestamp":1718767010000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1100-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1100-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,7]]},"article-number":"201"}}